SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Nanoparticles Reboot Blood Flow in Brain, Rice University and Baylor College of Medicine Study
August 24, 2012
 · 
1 min read
Lone Star Bio
Therapeutic Avenues for Parkinson’s Investigated, University of Houston Study
August 24, 2012
 · 
1 min read
Lone Star Bio
Common Antifungal Drug Decreases Tumor Growth and Shows Promise as Cancer Therapy, University of Texas Study
August 22, 2012
 · 
1 min read
Lone Star Bio
Brain Wave-Reading Robot Might Help Stroke Patients, Rice University Study
August 20, 2012
 · 
1 min read
Lone Star Bio
Metabolic Protein Wields Phosphate Group to Activate Cancer-Promoting Genes, University of Texas MD Anderson Cancer Center Study
August 17, 2012
 · 
1 min read
Lone Star Bio
New Technology Could Improve Treatment for Diabetes, Other Disorders, Texas A&M University Study
August 16, 2012
 · 
1 min read
Lone Star Bio
Using Light to “Tag And Track” Genetic Processes Much More Efficient, University of Texas Study
August 15, 2012
 · 
1 min read
Genetown
Blood Type May Boost Heart Disease Risk, Harvard Scientific Corp. Study
August 15, 2012
 · 
4 min read
Lone Star Bio
Berlin Heart, Inc.'s Ventricular Assist Device Helped Children More Than Heart-Lung Machine
August 10, 2012
 · 
10 min read
Lone Star Bio
Students With Strong Hearts and Lungs May Make Better Grades, University of North Texas Study
August 6, 2012
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board
November 5, 2024
 · 
5 min read
Press Releases
CrossBridge Bio Secures $10 Million Financing to Advance the Development of Next-Generation Dual-Payload ADC Therapies
November 5, 2024
 · 
3 min read
Press Releases
CorVel Announces Revenues and Earnings
November 5, 2024
 · 
4 min read
Press Releases
Lexicon to Present Preclinical IN VIVO Efficacy Data Demonstrating Ability of New Investigational Compound to Enhance and Maintain Semaglutide-Promoted Weight Loss
November 5, 2024
 · 
5 min read
Press Releases
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
November 5, 2024
 · 
1 min read
Press Releases
bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
November 4, 2024
 · 
5 min read
Press Releases
Castle Biosciences Reports Third Quarter 2024 Results
November 4, 2024
 · 
20 min read
Press Releases
CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
November 4, 2024
 · 
2 min read
Press Releases
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
November 4, 2024
 · 
2 min read
Press Releases
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th
November 4, 2024
 · 
2 min read
Load More